Archive | Healthcare RSS feed for this section

Electronic Laboratory Notebooks: Reinvigorating the LC-MS process

5 Jun

Electronic Laboratory Notebooks: Reinvigorating the LC-MS process

With the evolution of science and technology over the past 20 years, many lab operations are well developed. Data processing, review and reporting still remains a burden. The use of electronic laboratory notebooks (ELNs) could be the key to reinvigorating this process.

Continue Reading »

Can MedCity bring ‘coopertition’ to UK life sciences?

7 May

Can MedCity bring ‘coopertition’ to UK life sciences?

The recent news that Boris Johnson has launched MedCity is a welcome investment in the life sciences arena. It is encouraging to see the well-known research hubs of the UK, namely Oxford and Cambridge, are included in the ‘Golden triangle’ with London. The question to pose is whether the investment of £4 million is great enough? And it is essential to understand what MedCity will actually deliver.

Continue Reading »

Breaking down the barriers: multi-omics collaboration

23 Apr

translational medicine

Translational science, research and development (R&D) organizations and hospitals are starting to break down the barriers to open data collaboration. Most recently we’ve seen Johnson & Johnson agree on clinical trial data sharing with Yale School of Medicine. Other pharma companies are looking at removing cultural barriers by bringing teams closer together, both in mindset and location. But how easy is it to share information when it comes to multiple different omics data (multi-omics)?

Continue Reading »

Clinical trials data: sharing success

28 Aug

Andrew Jack’s recent article in the Financial Times touches on a hot debate across the pharmaceutical industry: should European and US drug companies be required to share clinical trials data with both researchers and competitors? Whilst many pharmaceutical and biotech firms are resisting regulators’ attempts to improve transparency, I would rather concentrate on how these companies can benefit from increased data sharing.

Continue Reading »

The Great Genome Gold Rush

28 May

A fascinating New York Times article on how US cancer centers are racing to map patients’ genes has made me think how personalized/precision medicine can be approached successfully. The article refers to an “an arms race within the war on cancer” as major academic medical centers spend and recruit heavily. As the US medical establishment moves towards the routine sequencing of every patient’s genome in the quest for precision medicine, most pundits are predicting a time when whole genome sequencing is ubiquitous throughout health care.

Continue Reading »